Sixera Pharma AB
556901-4763ActiveSmall biotech developing first treatment for rare Netherton syndrome.
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2012
- Founded
Key Decision Makers
Hans Olivecrona
Chief Medical Officer
Margit Mahlapuu
Chief Scientific Officer, Board member
Torbjörn Egelrud
Board member
Maria Klockare
Clinical Program Director
+5 more contacts in Funnelfeedr
Description
Sixera Pharma is a small biopharmaceutical company established in Stockholm in 2013. The company originated from a project spun out of Swedish Orphan Biovitrum (Sobi) and Arexis. Their core mission is to develop their lead compound, SXR1096, into the first available treatment for Netherton syndrome....
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556901476301
Decision Makers
9 contacts in FunnelfeedrHans Olivecrona
Chief Medical Officer
Margit Mahlapuu
Chief Scientific Officer, Board member
Torbjörn Egelrud
Board member
Maria Klockare
Clinical Program Director
Jean Nordström
Founder
William Gunnarsson
Board member
Maarten de Château
Chief Executive Officer, Board member
Thomas Eldered
Board member
Lennart Hansson
Chairman of the Board
Similar Companies
20 similar companies in FunnelfeedrOxThera AB
0 employeesDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
OxThera Intellectual Property AB
0 employeesDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
AUTHERA AS
5 employeesDeveloping novel FcRn-targeting biologics for therapeutic applications.
Devyser Diagnostics AB
1–4 employeesPioneering simple, fast, accurate genetic testing solutions for global laboratories.
Devyser AB
50–99 employeesPioneering simple, fast, accurate genetic testing solutions for global laboratories.
Browse More
Sixera Pharma AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo